# A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

> **NCT00642668** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 35 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta

## Key facts

- **NCT ID:** NCT00642668
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-30
- **Primary completion:** 2009-12-31
- **Final completion:** 2009-12-31
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00642668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00642668, "A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00642668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*